Cardiovascular Genetics Research Unit, EA4373, University of Lorraine, Nancy, France.
PLoS One. 2013;8(2):e55921. doi: 10.1371/journal.pone.0055921. Epub 2013 Feb 6.
Vascular endothelial growth factor (VEGF) is a key chemokine involved in tissue growth and organ repair processes, particularly angiogenesis. Elevated circulating VEGF levels are believed to play a role in type 2 diabetes (T2D) microvascular complications, especially diabetic retinopathy. Recently, a genome-wide association study identified two common single nucleotide polymorphisms (SNPs; rs6921438 and rs10738760) explaining nearly half of the variance in circulating VEGF levels. Considering the putative contribution of VEGF to T2D and its complications, we aimed to assess the effect of these VEGF-related SNPs on the risk of T2D, nephropathy and retinopathy, as well as on variation in related traits.SNPs were genotyped in several case-control studies: French and Danish T2D studies (N(cases) = 6,920-N(controls) = 3,875 and N(cases) = 3,561-N(controls) = 2,623; respectively), two French studies one for diabetic nephropathy (N(cases) = 1,242-N(controls) = 860) and the other for diabetic retinopathy (N(cases) = 1,336-N(controls) = 1,231). The effects of each SNP on quantitative traits were analyzed in a French general population-based cohort (N = 4,760) and two French T2D studies (N = 3,480). SNP associations were assessed using logistic or linear regressions.In the French population, we found an association between the G-allele of rs6921438, shown to increase circulating VEGF levels, and increased T2D risk (OR = 1.15; P = 3.7×10(-5)). Furthermore, the same allele was associated with higher glycated hemoglobin levels (β = 0.02%; P = 9.2×10(-3)). However, these findings were not confirmed in the Danes. Conversely, the SNP rs10738760 was not associated with T2D in the French or Danish populations. Despite having adequate statistical power, we did not find any significant effects of rs6921438 or rs10738760 on diabetic microvascular complications or the variation in related traits in T2D patients.In spite of their impact on the variance in circulating VEGF, we did not find any association between SNPs rs6921438 and rs10738760, and the risk of T2D, diabetic nephropathy or retinopathy. The link between VEGF and T2D and its complications might be indirect and more complex than expected.
血管内皮生长因子 (VEGF) 是一种参与组织生长和器官修复过程的关键趋化因子,特别是血管生成。循环 VEGF 水平升高被认为在 2 型糖尿病 (T2D) 微血管并发症中起作用,特别是糖尿病视网膜病变。最近,一项全基因组关联研究确定了两个常见的单核苷酸多态性 (SNP;rs6921438 和 rs10738760),它们解释了循环 VEGF 水平变化的近一半。考虑到 VEGF 对 T2D 及其并发症的潜在贡献,我们旨在评估这些与 VEGF 相关的 SNP 对 T2D、肾病和视网膜病变风险的影响,以及对相关特征变化的影响。在几个病例对照研究中对 SNP 进行了基因分型:法国和丹麦的 T2D 研究(病例数为 6920 例-对照组为 3875 例和病例数为 3561 例-对照组为 2623 例),两项法国研究,一项针对糖尿病肾病(病例数为 1242 例-对照组为 860 例),另一项针对糖尿病视网膜病变(病例数为 1336 例-对照组为 1231 例)。在一个基于法国人群的队列(N=4760)和两项法国 T2D 研究(N=3480)中分析了每个 SNP 对定量特征的影响。使用逻辑或线性回归评估 SNP 关联。在法国人群中,我们发现 rs6921438 的 G 等位基因与循环 VEGF 水平升高有关,并且与 T2D 风险增加有关(OR=1.15;P=3.7×10(-5))。此外,相同的等位基因与糖化血红蛋白水平升高有关(β=0.02%;P=9.2×10(-3))。然而,这些发现在丹麦人身上并未得到证实。相反,在法国人和丹麦人中,SNP rs10738760 与 T2D 无关。尽管我们具有足够的统计能力,但我们没有发现 rs6921438 或 rs10738760 对 T2D 患者的糖尿病微血管并发症或相关特征变化有任何显著影响。尽管它们对循环 VEGF 变异有影响,但我们没有发现 SNP rs6921438 和 rs10738760 与 T2D、糖尿病肾病或视网膜病变风险之间存在任何关联。VEGF 与 T2D 及其并发症之间的联系可能是间接的,比预期的更复杂。